POLYPEPTIDE GROUP AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.55 CHF | +2.43% |
|
+1.90% | +68.66% |
| Mar. 12 | PolyPeptide Group AG Provides Earnings Guidance for 2024 | CI |
| Mar. 12 | Transcript : PolyPeptide Group AG, 2023 Earnings Call, Mar 12, 2024 |
Business Summary
Number of employees: 1,273
Sales per Business
| CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Custom Projects
48.2
%
| 141 | 49.8 % | 150 | 48.2 % | +6.75% |
Contract Manufacturing
42.3
%
| 111 | 39.4 % | 132 | 42.3 % | +18.32% |
Generics and Cosmetics
9.5
%
| 30 | 10.7 % | 30 | 9.5 % | -2.08% |
Sales per region
| CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Europe and Asia
71.0
%
| 192 | 67.9 % | 221 | 71.0 % | +15.45% |
United States
29.0
%
| 90 | 32.1 % | 90 | 29.0 % | -0.41% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 23-04-11 | |
| Chief Tech/Sci/R&D Officer | 52 | 11-12-31 | |
Jens Fricke
COO | Chief Operating Officer | 59 | 22-11-30 |
Jane Anne Salik
BRD | Director/Board Member | 71 | 05-12-31 |
Michael Stäheli
IRC | Investor Relations Contact | 59 | 21-03-31 |
| General Counsel | 54 | 98-12-31 | |
Monika Casanova
HRO | Human Resources Officer | 45 | 22-05-08 |
| Sales & Marketing | 52 | 03-12-31 | |
| General Counsel | 46 | 21-08-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 20-12-31 | |
Peter Wilden
CHM | Chairman | 67 | 21-03-31 |
Jane Anne Salik
BRD | Director/Board Member | 71 | 05-12-31 |
Beat In-Albon
BRD | Director/Board Member | 72 | 20-12-31 |
Philippe Weber
BRD | Director/Board Member | 59 | 20-12-31 |
Erik Schropp
BRD | Director/Board Member | 60 | 20-12-31 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 33,125,001 | 12,958,584 ( 39.12 %) | 155,494 ( 0.4694 %) | 39.12 % |
Company contact information
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
30.26
EUR
Average target price
22.24
EUR
Spread / Average Target
-26.52%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +68.66% | 1.07B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- PPGN Stock
- Company PolyPeptide Group AG
